Baynes, J.W. and Thorpe, S.R. (1999) “Role of oxidative stress in diabetic complication—a new perspective on an old paradigm”, Diabetes
Bence, N.F., Sampat, R.M. and Kopito, R.R. (2001) “Impairment of the ubiquitin-proteasome system by protein aggregation”, Science (Washington, DC, US)
Benson, L.M., Naylor, S. and Tomlinson, A.J. (1998) “Investigation of Maillard reaction products using 15
N isotope studies and analysis by electrospray ionization-mass spectrometry”, Food Chem.
Booth, A.A., Khalifah, R.G., Todd, P. and Hudgon, B.G. (1997) “In vitro
kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways”, J. Biol. Chem.
Brownlee, M. (1995) “Advanced protein glycosylation in diabetes and aging”, Annu. Rev. Med.
Cai, J. and Hurst, H.E. (1999) “Identification and quantitation of N
-(carboxymethyl)valine adduct in hemoglobin by gas chromatography mass spectrometry”, J. Mass Spectrom.
Castellani, R., Smith, M.A., Richey, P.L. and Perry, G. (1996) “Glycoxidation and oxidative stress in Parkinson disease and diffuse Lewy body disease”, Brain Res.
Castellani, R.J., Perry, G., Harris, P.L.R., Monnier, V.M., Cohen, M.L. and Smith, M.A. (1997) “Advanced glycation modification of Rosenthal fibers in patients with Alexander disease”, Neurosci. Lett.
Castellani, R.J., Harris, P.L., Sayre, L.M., Fujii, J., Taniguchi, N., Vitek, M.P., Founds, H., Atwood, C.S., Perry, G. and Smith, M.A. (2001) “Active glycation in neurofibrillary pathology of Alzheimer disease: N
(epsilon)-(Carboxymethyl) lysine and hexitol-lysine”, Free Radic. Biol. Med.
Chellan, P. and Nagaraj, T.H. (1999) “Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes”, Arch. Biochem. Biophys.
Colaco, C. and Harrington, C.R. (1996) “Inhibitors of the Maillard reaction—potential in the treatment of Alzheimer's disease”, CNS Drugs
Calaco, C., Ledesma, M.D., Harrington, C.R. and Avilam, J. (1996) “The role of the Maillard reaction in other pathologies: Alzheimer's disease”, Nephrol. Dial. Transplant.
Coleman, III, W.M. (1999) “SPME-GC-MS detection analysis of Maillard reaction products”, Appl. Solid Phase Microextr., 585–608.
De Sa, P.F.G., Treubig, J.M., Brown, P.R. and Dain, J.A. (2001) “The use of capillary electrophoresis to monitor Maillard reaction products (MRP) by glyceraldehyde and the epsilon amino group of lysine”, Food Chem.
Devchand, K. and De Muelenaere, H.J.H. (1996) “Antioxidant activity of Maillard reaction products formed during extrusion”, SA J. Food Sci. Nutr.
Dickson, D.W. (1996) “Glycoxidation in Alzheimer's disease: a specific mechanism of early lesion pathogenesis?”, Alzheimer's Dis. Rev. (Electronic Publication)
Dukic-Stefanovic, S., Schinzel, R., Riederer, P. and Munch, G. (2001) “AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?”, Biogerontology
Durany, N., Munch, G., Michel, T. and Riederer, P. (1999) “Investigations on oxidative stress and therapeutical implications in dementia”, Eur. Arch. Psych. Clin. Neurosci.
Dyer, D.G., Blackledge, J.A., Thorpe, S.R. and Baynes, J.W. (1991) “Formation of pentosidine during nonenzymatic browning of proteins by glucose. Identification of glucose and other carbohydrates as possible precursors of pentosidine in vivo
”, J. Biol. Chem.
Eichner, K., Reutter, M. and Wittmann, R. (1990) “Detection of Maillard reaction intermediates by high-pressure liquid chromatography (HPLC) and gas chromatography”, Maillard React. Food Process., Hum. Nutr. Physiol., (Proc. Intl Symp. Maillard React.)
Fayle, S.E., Healy, J.P., Brown, P.A., Reid, E.A., Gerrard, J.A. and Ames, J.M. (2001) “Novel approaches to the analysis of the Maillard reaction of proteins”, Electrophoresis
Forbes, J.M., Soulis, T., Thallas, V., Panagiotopoulos, S., Long, D.M., Vasan, S., Wagle, D., Jerums, G. and Cooper, M.E. (2001) “Renoprotective effects of a novel inhibitor of advanced glycation”, Diabetologia
Frey, U., Retz, W., Riederer, P. and Rosler, M. (2000) “New aspects in antidemential drug therapy of Alzheimer's disease”, Aktuelle Neurol.
Giri, R., Shen, Y.M., Stins, M., Yan, S.D., Schmidt, A.M., Stern, D., Kim, K.S., Zlokovic, B. and Kalra, V.K. (2000) “beta-Amyloidinduced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1”, Am. J. Physiol.—Cell Physiol.
Glomb, M.A., Rosch, D. and Nagaraj, R.H. (2001) “N
-ornithine, a novel methylglyoxal-arginine modification in beer”, J. Agric. Food Chem.
Grandhee, S.K. and Monnier, V.M. (1991) “Mechanism of formation of the Maillard protein cross-link pentosidine. Glucose, fructose, and ascorbate as pentosidine precursors”, J. Biol. Chem.
Hayase, F., Nagaraj, R.H., Miyata, S., Njoroge, F.G. and Monnier, V.M. (1989) “Aging of proteins: immunological detection of a glucose-derived pyrrole formed during the Maillard reaction in vivo
”, J. Biol. Chem.
Hayase, F., Konishi, Y. and Kato, H. (1995) “Identification of the Modified structure of Arginine residues in proteins with 3-Deoxyglucosone, a Maillard reaction intermediate”, Biosci. Biotechnol. Biochem.
Heidrich, A., Rosler, M. and Riederer, P. (1997) “Pharmacotherapy in Alzheimer's dementia: treatment of cognitive symptoms—results of new studies”, Forschritte Neurol. Psychiatr.
Homoki-Farkas, P., Orsi, F. and Kroh, L.W. (1997) “Methylglyoxal determination from different carbohydrates during heat processing”, Food Chem.
Horie, K., Miyata, T., Yasuda, T., Takeda, A., Yasuda, Y., Maeda, K., Sobue, G. and Kurokawa, K. (1997) “Immunohistochemical localization of advanced glycation end products, pentosidine, and carboxymethyllysine in lipofuscin pigments of Alzheimer's disease and aged neurons”, Biochem. Biophys. Res. Commun.
Horvat, S., Varga-Defterdarovic, L. and Horvat, J. (1998) “Synthesis of novel imidazolidinones from hexose-peptide adducts: model studies of the Maillard reaction with possible significance in protein glycation”, Chem. Commun. (Cambridge), 1663–1664.
Horvat, S., Roscic, M. and Horvat, J. (1999) “Synthesis of hexoserelated imidazolidinones: novel glycation products in the Maillard reaction”, Glycoconj. J.
Kimura, T., Takamatsu, J., Araki, N., Goto, M., Kondo, A., Miyakawa, T. and Horiuchi, S. (1995) “Are advanced glycation end-products associated with amyloidosis in Alzheimer's disease?”, NeuroReport
Kimura, T., Ikeda, K., Takamatsu, J., Miyata, T., Sobue, G., Miyakawa, T. and Horiuchi, S. (1996) “Identification of advanced glycation end products of the Maillard reaction in Pick's disease”, Neurosci. Lett.
Ko, L.W., Ko, E.C., Nacharaju, P., Liu, W.K., Chang, E., Kenessey, A. and Yen, S.H. (1999) “An immunochemical study on tau glycation in paired helical filaments”, Brain Res.
Lapolla, A., Fedele, D., Martano, L., Arico, N.C., Garbeglio, M., Traldi, P., Seraglia, R. and Favretto, D. (2001) “Advanced glycation end products: a highly complex set of biologially relevant compounds detected by mass spectrometry”, J. Mass Spectrom.
Larisch, B., Gross, U. and Pischetsrieder, M. (1998) “On the reaction of l
-ascorbic acid with propylamine under various conditions. Quantification of the main products by HPLC/DAD”, Z. Lebensm.—Unters. Forsch. A
Lederer, M.O. and Buhler, H.P. (1999) “Cross-linking of proteins by Maillard processes-characterization and detection of a lysine-arginine cross-link derived from d
-glucose”, Bioorg. Med. Chem.
Lederer M.O., Gerum, F. and Severin, T. (1998) “Cross-linking of proteins by Maillard processes—model reactions of d
-glucose or methylglyoxal with butylamine and guanidine derivatives”, Bioorg. Med. Chem.
Lederer, M.O. and Klaiber, R.G. (1999) “Cross-linking of proteins by Maillard processes: characterization and detection of lysine-arginine cross-links derived from glyoxal and methylglyoxal”, Bioorg. Med. Chem.
Ledesma, M.D., Bonay, P., Colaco, C. and Avila, J. (1994) “Analysis of microtubule-associated protein tau glycation in paired helical filaments”, J. Biol. Chem.
Ledl, F. and Schleicher, E. (1990) “New aspects of the Maillard reaction in foods and in the human body”, Angew Chem. Int. Ed. Engl.
Li, J.J., Surini, M., Catsicas, S., Kawashima, E. and Bouras, C. (1995) “Age-Dependent accumulation of avadenced glycosylation end-products in human neurons”, Neurobiol. Aging
Li, J.J., Dickson, D., Hof, P.R. and Vlassara, H. (1998) Receptors for advanced glycosylation endproducts in human brain: role in brain homeostasis”, Mol. Med.
Linetsky, M., Lagrand, R.D., Mossine, V.V. and Ortwerth, B.J. (2001), Appl. Biochem. Biotechnol.
, 71–96, Sugar-mediated crosslinking of alpha-biotinylated-Lys to cysteamine-agarose support: a method to isolate Maillard Lys-Lys-like crosslinks.PubMedCrossRef
Litchfield, J.E., Thorpe, S.R. and Baynes, J.W. (1999) “Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo
”, Int. J. Biochem. Cell Biol.
Loske, C., Gerdemann, A., Schepl, W., Wycislo, M., Schinzel, R., Palm, D., Riederer, P. and Munch, G. (2000) “Transition metalmediated glycoxidation accelerates cross-linking of beta-amyloid peptide”, Eur. J. Biochem.
Madaj, J., Nishikawa, Y., Reddy, V.P., Rinaldi, P., Kurata, T. and Monnier, V.M. (2000) “6-Deoxy-6-fluoro-l
-ascorbic acid: crystal structure and oxidative degradation”, Carbohydr. Res.
Mark, R.J., Lovell, M.A., Markesbery, W.R., Uchida, K. and Mattson, M.P. (1997) “A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid betapeptide”, J. Neurochem.
Mastrocola, D. and Munari, M. (2000) “Progress of the Maillard reaction and antioxidant action of Maillard reaction products in preheated model systems during storage”, J. Agric. Food Chem.
Mattson, M.P., Carney, J.W. and Butterfield, D.A. (1995) “A tombstone in Alzheimer's?”, Nature
Mcpherson, J.D., Shilton, B.H. and Walton, D.J. (1988) “Role of fructose in glycation and cross-linking of proteins”, Biochemistry
Miyata, S. and Monnier, V. (1992) “Immunohistochemical detection of advanced glycosylation end products in diabetic tissues using monoclonal antibody to pyrraline”, J. Clin. Investig.
Mizutari, K., Ono, T., Ikeda, K., Kayashima, K. and Horiuchi, S. (1997) “Photo-enhanced modification of human skin elastin in actinic elastosis by N
-epsilon-(carboxymethyl)lysine, one of the glycoxidation products of the Maillard reaction”, J. Investig. Dermatol.
Monnier, V.M. (1999) “Glycation, glycoxidation, and other Maillard reaction products”, Methods Aging Res., 657–681.
Monnier, V.M., Nagaraj, R.H., Portero-Otin, M., Glomb, M., Elgawish, A.H., Sell, D.R. and Friedlander, M.A. (1996) “Structure of advanced Maillard reaction products and their pathological role”, Nephrol. Dial., Transplant.
Monti, S.M., Ritieni, A., Graziani, G., Randazzo, G., Mannina, L., Segre, A. L. and Fogliano, V. (1999) “LC/MS analysis and antioxidative efficiency of Maillard reaction products from a lactose-lysine model system”, J. Agric. Food Chem.
Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Titani, K. and Ihara, Y. (1993) “Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments”, Neuron
Munch, G., Taneli, Y., Schraven, E., Schindler, U., Schinzel, R., Palm, D. and Riederer, P. (1994) “The Cognition-enhancing drug tenilsetam is an inhibitor of protein cross-linking by advanced glycosylation”, J. Neural Transm.—Park. Dis. Dement. Sect.
Munch, G., Mayer, S., Michaelis, J., Hipkiss, A.R., Riederer, P., Muller, R., Neumann, A., Schinzel, R. and Cunningham, A.M. (1997a) “Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of beta-amyloid peptide”, Biochim. Biophys. Acta
Munch, G., Thome, J., Foley, P., Schinzel, R. and Riederer, P. (1997b) “Advanced glycation endproducts in ageing and Alzheimer's disease”, Brain Res. Rev.
Munch, G., Cunningham, A.M., Riederer, P. and Braak, E. (1998a) “Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease”, Brain Res.
Munch, G., Schinzel, R., Loske, C., Wong, A., Durany, N., Li, J.J., Vlassara, H., Smith, M.A., Perry, G. and Riederer, P. (1998b) “Alzheimer's disease—synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts”, J. Neural Transm.
Munch, G., Schicktanz, D., Behme, A., Gerlach, M., Riederer, P., Palm, D. and Schinzel, R. (1999) “Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library”, Nat. Biotechnol.
Munch, G., Luth, H.J., Wong, A., Arendt, T., Hirsch, E., Ravid, R. and Riederer, P. (2000) “Crosslinking of alpha-synuclein by advanced glycation endproducts—an early pathophysiological step in Lewy body formation?”, J. Chem. Neuroanat.
Nagaraj, R.H. and Sady, C. (1996) “The presence of a glucosederived Maillard reaction product in the human lens”, FEBS Lett.
Nagaraj, R.H., Porterootin, M. and Monnier, V.M. (1996a) “Pyrraline ether crosslinks as a basis for protein crosslinking by the advanced Maillard reaction in aging and diabetes”, Arch. Biochem. Biophys.
Nagaraj, R.H., Shipanova, I.N. and Faust, F.M. (1996b) “Protein cross-linking by the Maillard reaction—isolation, characterization, and in vivo
detection of a lysine-lysine cross-link derived from methylglyoxal”, J. Biol. Chem.
Nakamura, K., Hasegawa, T., Fukunaga, Y. and Ienaga, K. (1992) “Crosslines A and B as candidates for the fluorophores in age-and diabetes-related cross-linked proteins, and their diacetates produced by Maillard reaction of a-N-acetyl-l-lysine wid d-glucose”, J. Chem. Soc. Chem. Commun., 992–994.
Neumann, A., Schinzel, R., Palm, D., Riederer, P. and Munch, G. (1999) “High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-kappa B activation and cytokine expression”, FEBS Lett.
Niwa, T. and Tsukushi, S. (2001) “3-Deoxyglucosone and AGEs in uremic complications: inactivation of glutathione peroxidase by 3-deoxyglucosone”, Kidney Int.
Niwa, T., Sato, M., Katsuzaki, T., Tomoo, T., Miyazaki, T., Tatemichi, N., Takei, Y. and Kondo, T. (1996) “Amyloid beta(2)-microglobulin is modified with N
-epsilon-(carboxymethyl) lysine in dialysis-related amyloidosis”, Kidney Int.
Niwa, T., Katsuzaki, T., Miyazaki, S., Miyazaki, T., Ishizaki, Y., Hayase, F., Tatemichi, N. and Takei, Y. (1997a) “Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients”, J. Clin. Investig.
Niwa, T., Katsuzaki, T., Miyazaki, S., Momoi, T., Akiba, T., Miyazaki, T., Nokura, K., Hayase, F., Tatemichi, N. and Takei, Y. (1997b) “Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis”, Kidney Int.
Niwa, T., Katsuzaki, T., Miyazaki, S., Momoi, T., Akiba, T., Miyazaki, T., Nokura, K., Hayase, F., Tatemichi, N. and Takei, Y. (1997c) “Amyloid beta(2)-microglobulin is modufied with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis”, Kidney Int.
Niwa, H., Takeda, A., Wakai, M., Miyata, T., Yasuda, Y., Mitsuma, T., Kurokawa, K. and Sobue, G. (1998) “Accelerated formation of N
epsilon-(carboxymethyl) lysine, and advanced glycation end product, by glyoxal and 3-deoxyglucosone in cultured rat sensory neurons”, Biochem. Biophys. Res. Commun.
Obayashi, H., Nakano, K., Shigeta, H., Yamaguchi, M., Yoshimori, K., Fukui, M., Fujii, M., Kitagawa, Y., Nakamura, N.,. Nakamura, K., Nakazawa, Y., Ienaga, K., Ohta, M., Nishimura, M., Fukui, I. and Kondo, M. (1996) “Formation of crossline as a fluorescent advanced glycation end product in vitro
and in vivo
”, Biochem. Biophys. Res. Commun.
Odani, H., Shinzato, T., Matsumoto, Y., Takai, I., Nakai, S., Miwa, M., Iwayama, N., Amano, I. and Maeda, K. (1996) “First evidence for accumulation of protein-bound and protein-free pyrraline in human uremic plasma by mass spectrometry”, Biochem. Biophys. Res. Commun.
Odetti, P., Angelini, G., Dapino, D., Zaccheo, D., Garibaldi, S., Dagna-Bricarelli, F., Piombo, G., Perry, G., Smith, M., Traverso, N. and Tabaton, M. (1998a) “Early glycoxidation damage in brains from Down's syndrome”, Biochem. Biophys. Res. Commun.
Odetti, P., Angelini, G., Dapino, D., Zaccheo, D., Garibaldi, S., Dagna-Bricarelli, F., Piombo, G., Perry, G., Smith, M., Traverso, N. and Tabaton, M. (1998b) “Early glycoxidation damage in brains from Down's syndrome”, Biochem. Biophys. Res. Commun.
Odetti, P., Garbaldi, S., Norese, R., Angelini, G., Marinelli, L., Valentini, S., Menini, S., Traverso, N., Zaccheo, D., Siedlak, S., Perry, G., Smith, M.A. and Tabaton, M. (2000) “Lipoperoxidation is selectively involved in progressive supranuclear palsy”, Neuropathol. Exp. Neurol.
Ohgami, N., Nagai, R., Nakayama, H., Ikemoto, M. and Horiuchi, S. (2000) “CD36, a member of class B scavenger receptor family, as a receptor for advanced glycation end products”, Diabetes
Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Kuniyasu, A., Horiuchi, S., and Nakayama, H. (2001) “CD36, a member of the class B scavenger receptor family, as a receptor for advanced glycation end products”, J. Biol. Chem.
Okamoto, G., Hayase, F. and Kato, H. (1992) “Scavenging of active oxygen species by glycated proteins”, Biosci., Biotechnol., Biochem., 56, 928–931.
Pari. K., Sundari, C.S., Chandani, S. and Balasubramanian, D. (2000) “beta-Carbolines that accumulate in human tissues may serve a protective role against oxidative stress”, J. Biol. Chem.
Pedersen, W.A., Cashman, N.R. and Mattson, M.P. (1999) “The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells”, Exp. Neurol.
Perez, M., Cuadros, R., Smith, M.A., Perry, G. and Avila, J. (2000) “Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation product, 4-hydroxy-2-nonenal” FEBS Lett.
Perry, G., Nunomura, A. and Smith, M.A. (1999) “Antioxidant reversal of oxidative stress-induced memory deficits”, Neuroreport
Porretta, S. (1992) “Chromatographic analysis of Maillard reaction products”, J. Chromatogr.
Porterootin, M., Nagaraj, R.H. and Monnier, V.M. (1995) “Chromatographic evidence for Pyrraline formation during protein glycation in-vitro and in-vivo”, Biochim. Biophys. Acta—Protein Struct. Molec. Enzym.
Rahbar, S., Kumar Yernini, K., Scott, S., Gonzales, N. and Lalezari, I. (1999) “Novel inhibitors of advanced glycation end-products”, Biochem. Biophys. Res. Commun.
Roberts, R.L. and Lloyd, R.V. (1997) “Free radical formation from secondary amines in the Maillard reaction”, J. Agric. Food Chem.
Roscic, M., Versluis, C., Kleinnijenhuis, A.J., Horvat, S. and Heck, A.J. (2001) “The early glycation products of the Maillard reaction: mass spectrometric characterization of novel imidazolidinones derived from an opioid pentapeptide and glucose”, Rapid Commun. Mass Spectrom.
Rosler, M., Retz, W., Thome, J. and Riederer, P. (1998) “Free radicals in Alzheimer's dementia: currently available therapeutic strategies”, J. Neural Transm., Suppl.
Royle, L., Bailey, R.G. and Ames, J.M. (1998) “Separation of Maillard reaction products from xylose-glycine and glucose-glycine model systems by capillary electrophoresis and comparison to reverse phase HPLC”, Food Chem.
Saez-Valero, J. and Small, D.H. (2001) “Altered glycosylation of cerebrospinal fluid butyrylcholinesterase in Alzheimer's disease”, Brain Res.
Salinero, O., Moreno-Flores, M.T. and Wandosell, F. (2000) “Increasing neurite outgrowth capacity of β-amyloid precursor protein proteoglycan in Alzheimer's disease”, J. Neurosci. Res.
Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M. and Makita, Z. (2001) “Immunohistochemical distribution of the receptor for advanced glycation end products in neurons and astrocytes in Alzheimer's disease”, Brain Res.
Sato, Y., Naito, Y., Grundke-Iqbal, I., Iqbal, K. and Endo, T. (2001) “Analysis of N
-glycans of pathological tau: possible occurrence of aberrant processing of tau in Alzheimer's disease”, FEBS Lett.
Saxena, A.K., Saxena, P., Wu, X.L., Obrenovich, M., Weiss, M.F. and Monnier, V.M. (1999) “Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: relevance to diseases of glycoxidative stress”, Biochem. Biophys. Res. Commun.
Sayre, L.M., Zelasko, D.A., Harris, P.L.R., Perry, G., Salomon, R.G. and Smith, M.A. (1997) “4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease”, J. Neurochem.
Sayre, L.M., Smith, M.A. and Perry, G. (2001) “Chemistry and biochemistry of oxidative stress in neurodegenerative disease”, Curr. Med. Chem.
Schippling, S., Kontush, A., Arlt, S., Buhmann, C., Sturenburg, H.J., Mann, U., Muller-Thomsen, T. and Beisiegel, U. (2000) “Increased lipoprotein oxidation in Alzheimer's disease”, Free Radic. Biol. Med.
Schmidt, A.M., Yan, S.D., Wautier, J.L. and Stern, D. (1999) “Activation of receptor for advanced glycation end products—a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis”, Circ. Res.
Schmidt, A.M., Yan, S.D., Yan, S.F. and Stern, D.M. (2000) “The biology of the receptor for advanced glycation end products and its ligands”, Biochim. Biophys. Acta—Mol. Cell Res.
Seidl, R., Schuller, E., Cairns, N. and Lubec, G. (1997) “Evidence against increased glycoxidation in patients with Alzheimer's disease”, Neurosci. Lett.
Sell, D.R. and Monnier, V.M. (1989) “Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process”, J. Biol. Chem.
Sell, D.R., Nagaraj, R.H., Grandhee, S.K., Odetti, P., Lapolla, A., Fogarty, J. and Monnier, V.M. (1991) “Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia”, Diabetes Metab. Rev.
Sell, D.R., Primc, M., Schafer, I.A., Kovach, M., Weiss, M.A. and Monnier, V.M. (1998) “Cell-associated pentosidine as a marker of aging in human diploid cells in vitro
and in vivo
”, Mech. Ageing Dev.
Shipanova, I.N., Glomb, M.A. and Nagaraj, R.H. (1997) “Protein modification by methylglyoxal: chemical nature and synthetic mechanism of a major fluorescent adduct”, Arch. Biochem. Biophys.
Shoda, H., Miyata, S., Liu, B.F., Yamada, H., Ohara, T., Suzuki, K., Oimomi, M. and Kasuga, M. (1997) “Inhibitory effects of tenilsetam on the maillard reaction”, Endocrinology
Shuvaev, V.V., Laffont, I., Serot, J.M., Fujii, J., Taniguchi, N. and Siest, G. (2001) “Increased protein glycation in cerebrospinal fluid of Alzheimer's disease”, Neurobiol. Aging
Singh, R., Barden, A., Mori, T. and Beilin, L. (2001) “Advanced glycation end-products: a review”, Diabetologia
Smith, M.A., Richey, P.L., Taneda, S., Kutty, R.K., Sayre, L.M., Monnier, V.M. and Perry, G. (1994a) “Advanced Maillard reaction end-products. Free-radicals, and protein oxidation in Alzheimer's-disease”, Annal. NY Acad. Sci.
Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.-D., Stern, D., Sayre, L.M., Monnier, V.M. and Perry, G. (1994b) “Advanced Maillard reaction end products are associated with Alzheimer disease pathology”, Proc. Natl Acad. Sci. USA
Smith, M.A., Sayre, L.M., Vitek, M.P., Monnier, V.M. and Perry, G. (1995a) “Early aging and Alzheimers”, Nature
Smith, M.A., Taneda, S., Richey, P.L., Miyata, S., Yan, S.D., Stern, D., Sayre, L.M., Monnier, V.M. and Perry, G. (1995b) “Advanced Maillard reaction end-products are associated with Alzheimer-disease pathology”, Proc. Natl Acad. Sci. USA
, 1794–1794; and 91
Smith, M.A., Sayre, L.M., Anderson, V.E., Harris, P.L.R., Beal, M.F., Kowall, N. and Perry, G. (1998) “Cytochemical demonstration of oxidative damage in Alzheimer disease by immunochemical enhancement of the carbonyl reaction with 2,4-dinitrophenylhydrazine”, J. Histochem. Cytochem.
Sugimoto, H. (1999) “Structure-activity relationships of acetylcholinesterase inhibitors: donepezil hydrochloride for the treatment of Alzheimer's disease”, Pure Appl. Chem.
Tabaton, M., Perry, G., Smith, M., Vitek, M., Angelini, G., Dapino, D., Garibaldi, S., Zaccheo, D. and Odetti, P. (1997) “Is amyloid beta-protein glycated in Alzheimer's disease?”, Neuroreport
Takahashi, M., Tsujioka, Y., Yamada, T., Tsuboi, Y., Okada, H., Yamamoto, T. and Liposits, Z. (1999) “Glycosylation of microtubule-associated protein tau in Alzheimer's disease brain”, Acta Neuropathol.
Takeda, A., Yasuda, T., Miyata, T., Goto, Y., Wakai, M., Watanabe, M., Yasuda, Y., Horie, K., Inagaki, T., Doyu, M., Maeda, K. and Sobue, G. (1998) “Advanced glycation end products colocalized with astrocytes and microglial cells in Alzheimer's disease brain”, Acta Neuropathol.
Takeda, A., Smith, M.A., Avila, J., Nunomura, A., Siedlak, S.L., Zhu, X.W., Perry, G. and Sayre, L.M. (2000) In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification”, J. Neurochem.
Takeda, A., Wakai, M., Niwa, H., Dei, R., Yamamoto, M., Li, M., Goto, Y., Yasuda, T., Nakagomi, Y., Watanabe, M., Inagaki, T., Yasuda, Y., Miyata, T. and Sobue, G. (2001) “Neuronal and glial advanced glycation end product [N
-epsilon-(carboxymethyl)lysine] in Alzheimer's disease brains”, Acta Neuropathol.
Takeuchi, M., Bucala, R., Suzuki, T., Ohkubo, T., Yamazaki, M., Koike, T., Kameda, Y. and Makita, Z. (2000) “Neurotoxicity of advanced glycation end-products for cultured cortical neurons”, J. Neuropathol. Exp. Neurol.
Tessier, F., Obrenovich, M. and Monnier, V.M. (1999) “Structure and mechanism of formation of human lens fluorophore LM1—relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis”, J. Biol. Chem.
Thorpe, S.R. and Baynes, J.W. (1996) “Role of the maillard reaction in diabetes mellitus and diseases of aging”, Drugs Aging
Tomlinson, A.J., Landers, J.P., Lewis, I.A.S. and Naylor, S. (1993) “Buffer conditions affecting the separation of Maillard reaction products by capillary electrophoresis”, J. Chromatogr.
Uesugi, N., Sakata, N., Nagai, R., Jono, T., Horiuchi, S. and Takebayashi, S. (2000) “Glycoxidative modification of AA amyloid deposits in renal tissue”, Nephrol. Dial. Transplant.
Ulrich, P. and Cerami, A. (2001) “Protein glycation, diabetes, and aging”, Recent Prog. Horm. Res.
Vitek, M.P., Bhattacharya, K., Glendening, J.M., Stopa, E., Vlassara, H., Bucala, R., Manogue, K. and Cerami, A. (1994) “Advanced glycation end products contribute to amyloidosis in Alzheimer disease”, Proc. Natl Acad. Sci. USA
Vlassara, H., Bucala, R. and Striker, L. (1994) “Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging”, Lab. Investig.
Wang, J.Z., Gong, C.X., Zaidi, T., Grundke-Iqbal, I. and Iqbal, K. (1995) “Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and-2B”, J. Biol. Chem.
Wang, J.-Z., Grundke-Iqbal, I. and Iqbal, K. (1996a) “Glycosylation of microtubule-associated protein tau: an abnormal post-translational modification in Alzheimer's disease”, Nat. Med. (NY)
Wang, J.-Z., Grundke-Iqbal, I. and Iqbal, K. (1996b) “Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A,-2B and-1”, Mol. Brain Res.
Wang, M., Jin, Y., Li, J. and Ho, C.-T. (1999) “Two novel β-Carboline compounds from the Maillard reaction between Xylose and Tryptophan”, J. Agric. Food Chem.
Weber, K., Schmahl, W. and Munch, G. (1998) “Distribution of advanced glycation end products in the cerebellar neurons of dogs”, Brain Res.
Wilker, S.C., Chellan, P., Arnold, B.M. and Nagaraj, R.H. (2001) “Chromatographic quantification of argpyrimidine, a methylglyoxal-derived product in tissue proteins: comparison with pentosidine”, Anal. Biochem.
Wolffenbuttel, B.H.R., Boulanger, C.M., Crijns, F.R.L., Huijberts, M.S.P., Poitevin, P., Swennen, G.N.M., Vasan, S., Egan, J.J., Ulrich, P., Cerami, A. and Levy, B.I. (1998a) “Breakers of advanced glycation end products restore large artery properties in experimental diabetes”, Proc. Natl Acad. Sci. USA
Wolffenbuttel, B.H.R., Boulanger, C.M., Crijns, F.R.L., Poitevin, P., Egan, J.J., Cerami, A. and Levy, B.I. (1998b) “ALT-711, a breaker of advanced glycation endproducts (AGEs), restores large artery elasticity in experimental diabetes”, Diabetes
Yamaguchi, M., Nakamura, N., Nakano, K., Kitagawa, Y., Shigeta, H., Hasegawa, G., Ienaga, K., Nakamura, K., Nakazawa, Y., Fukui, I., Obayashi, H. and Kondo, M. (1998) “Immunochemical quantification of crossline as a fluorescent advanced glycation endproduct in erythrocyte membrane proteins from diabetic patients with or without retinopathy”, Diabetic Med.
Yan, S.D., Chen, X., Schmidt, A.M., Brett, J., Godman, G., Zou, Y.S., Scott, C.W., Caputo, C., Frappier, T., Smith, M.A., Perry, G., Yen, S.H. and Stern, D. (1994) “Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress”, Proc. Natl Acad. Sci. USA
Yan, S.D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D. and Schmidt, A.M. (1996) “RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease”, Nature
Yan, S.D., Fu, J., Soto, C., Chen, X., Zhu, H.J., Almohanna, F., Collison, K., Zhu, A.P., Stern, E., Saido, T., Tohyama, M., Ogawa, S., Roher, A. and Stern, D. (1997) “An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease”, Nature
Yan, S.D., Stern, D., Kane, M.D., Kuo, Y.M., Lampert, H.C. and Roher, A.E. (1998) “RAGE—a beta interactions in the pathophysiology of Alzheimer's disease”, Restor. Neurol. Neurosci.
Yan, S.D., Roher, A., Chaney, M., Zlokovic, B., Schmidt, A.M. and Stern, D. (2000) “Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide”, Biochim. Biophys. Acta-Mol. Basis Dis.
Yoshimura, Y., Iijima, T., Watanabe, T. and Nakazawa, H. (1997) “Antioxidative effect of Maillard reaction products using glucose-glycine model system”, J. Agric. Food Chem.
Zyzak, D.V., Richardson, J.M., Thorpe, S.R. and Baynes, J.W. (1995) “Formation of reactive intermediates from Amadori compounds under physiological Conditions”, Arch. Biochem. Biophys.